2 A recent report from the Centers for Disease ... About NARCAN ® Nasal Spray NARCAN ® Naloxone HCl Nasal Spray 4 mg is the first FDA-approved, over-the-counter (OTC) 4 mg naloxone product ...

Padagis OTC Naloxone HCl Nasal Spray, 4 mg, is an original prescription-strength solution designed to rapidly reverse the effects of a life-threatening opioid emergency. The spray is easy to use ...

Emergent distributes NARCAN® Nasal Spray 4 mg, which is the first FDA-approved over-the-counter naloxone product for the emergency treatment of opioid overdose. Under the terms of the ...

Emergent distributes NARCAN Nasal Spray 4 mg, which is the first FDA-approved over-the-counter naloxone product for the emergency treatment of opioid overdose. Under the terms of the six-year ...

GAITHERSBURG, Md., Jan. 14, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that it has entered into an agreement to obtain exclusive commercial rights in the U.S ...

Hikma will continue producing its 8 mg naloxone HCl nasal spray in its Columbus, Ohio manufacturing facility and will provide it to Emergent as its exclusive commercial partner. "We are thrilled ...

Alongside over-the-counter NARCAN ® Nasal Spray 4 mg, prescription KLOXXADO ® (naloxone HCl) Nasal Spray 8 mg will expand Emergent’s ability to distribute multiple life-saving opioid overdose ...

“Meeting the needs of our patients and customers by now offering two nasal naloxone products at different strengths – NARCAN ® Nasal Spray 4 mg and KLOXXADO ® Nasal Spray 8 mg – allows Emergent to do ...

2 A recent report from the Centers for Disease ... About NARCAN ® Nasal Spray NARCAN ® Naloxone HCl Nasal Spray 4 mg is the first FDA-approved, over-the-counter (OTC) 4 mg naloxone product ...